Cargando…

Anti-Fibrotic Effect of Losartan, an Angiotensin II Receptor Blocker, Is Mediated through Inhibition of ER Stress via Up-Regulation of SIRT1, Followed by Induction of HO-1 and Thioredoxin

Endoplasmic reticulum (ER) stress is increasingly identified as modulator of fibrosis. Losartan, an angiotensin II receptor blocker, has been widely used as the first choice of treatment in chronic renal diseases. We postulated that anti-fibrotic effect of losartan is mediated through inhibition of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyosang, Baek, Chung Hee, Lee, Raymond Bok, Chang, Jai Won, Yang, Won Seok, Lee, Sang Koo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5343841/ https://www.ncbi.nlm.nih.gov/pubmed/28146117 http://dx.doi.org/10.3390/ijms18020305

Ejemplares similares

The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats
por: Siregar, Safendra, et al.
Publicado: (2023)

Angiotensin receptor blocker Losartan inhibits tumor growth of colorectal cancer
por: Hashemzehi, Milad, et al.
Publicado: (2021)

The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma
por: Coulson, Rhiannon, et al.
Publicado: (2017)

Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat
por: Yoshiji, Hitoshi, et al.
Publicado: (2009)

Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD
por: Wouda, Rosa D, et al.
Publicado: (2021)

Beneficial Role of HO-1-SIRT1 Axis in Attenuating Angiotensin II-Induced Adipocyte Dysfunction
por: Lakhani, Hari Vishal, et al.
Publicado: (2019)

Pre-treatment with the angiotensin receptor 1 blocker losartan protects renal blood flow and oxygen delivery after propofol-induced hypotension in pigs
por: Franzén, Stephanie, et al.
Publicado: (2020)

Combined therapeutic benefit of mitochondria-targeted antioxidant, MitoQ(10), and angiotensin receptor blocker, losartan, on cardiovascular function
por: McLachlan, Jennifer, et al.
Publicado: (2014)

The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects
por: Takagi, Hirotetsu, et al.
Publicado: (2021)

Curcuma aromatica Salisb. Protects from Acetaminophen-Induced Hepatotoxicity by Regulating the Sirt1/HO-1 Signaling Pathway
por: Kim, Hyunseong, et al.
Publicado: (2023)

Angiotensin II type 1 receptor blocker losartan attenuates locomotor, anxiety-like behavior, and passive avoidance learning deficits in a sub-chronic stress model
por: Ranjbar, Hoda, et al.
Publicado: (2018)

The effect of angiotensin 1-7 and losartan on renal ischemic/reperfusion injury in male rats
por: Safari, Tahereh, et al.
Publicado: (2019)

A randomised controlled trial of losartan as an anti-fibrotic agent in non-alcoholic steatohepatitis
por: McPherson, Stuart, et al.
Publicado: (2017)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Cytosolic thioredoxin reductase 1 is required for correct disulfide formation in the ER
por: Poet, Greg J, et al.
Publicado: (2017)

Therapeutic Effect of Losartan, an Angiotensin II Type 1 Receptor Antagonist, on CCl(4)-Induced Skeletal Muscle Injury
por: Hwang, Ok-Kyung, et al.
Publicado: (2016)

Effect of Angiotensin II Type 1 Receptor Antagonist, Losartan on Inflammatory Factor in Atherosclerotic Rabbits
por: Xu, Yan-min, et al.
Publicado: (2013)

AT1R blocker losartan attenuates intestinal epithelial cell apoptosis in a mouse model of Crohn's disease
por: LIU, TIAN-JING, et al.
Publicado: (2016)

Severe Hyponatremia Associated with the Use of Angiotensin II Receptor Blocker/thiazide Combinations
por: Kim, Da-Rae, et al.
Publicado: (2013)

Angiotensin II Receptor Blocker Irbesartan Enhanced SIRT1 longevity Signaling Replaces the Mitochondrial Biogenetic Survival Pathway to Attenuate Hypertension-Induced Heart Apoptosis
por: Pai, Pei-Ying, et al.
Publicado: (2022)

Angiotensin II type 1 receptor blockers as a first choice in patients with acute myocardial infarction
por: Lee, Jang Hoon, et al.
Publicado: (2016)

Novel Insights into the Antagonistic Effects of Losartan against Angiotensin II/AGTR1 Signaling in Glioblastoma Cells
por: Panza, Salvatore, et al.
Publicado: (2021)

Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models
por: Datta, Meenal, et al.
Publicado: (2023)

Angiotensin type 1 receptor antagonist losartan, reduces MPTP-induced degeneration of dopaminergic neurons in substantia nigra
por: Grammatopoulos, Tom N, et al.
Publicado: (2007)

Anti-Fibrotic Potential of Angiotensin (1-7) in Hemodynamically Overloaded Rat Heart
por: Sykora, Matus, et al.
Publicado: (2023)

Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
por: Lee, Hyun Woo, et al.
Publicado: (2021)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

Thioredoxin-1 Promotes Mitochondrial Biogenesis Through Regulating AMPK/Sirt1/PGC1α Pathway in Alzheimer's Disease
por: Jia, Jinjing, et al.
Publicado: (2023)

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation
por: Park, Jeong-Hwan, et al.
Publicado: (2009)

The Angiotensin Type 1 Receptor Antagonist Losartan Prevents Ovariectomy-Induced Cognitive Dysfunction and Anxiety-Like Behavior in Long Evans Rats
por: Campos, Glenda V., et al.
Publicado: (2019)

Losartan and isoproterenol promote alterations in the local renin-angiotensin system of rat salivary glands
por: Cano, Isadora Prado, et al.
Publicado: (2019)

Renin angiotensin system blockage by losartan neutralize hypercholesterolemia-induced inflammatory and oxidative injuries
por: AlSaad, Abdulaziz M.S., et al.
Publicado: (2020)

Esomeprazole attenuates inflammatory and fibrotic response in lung cells through the MAPK/Nrf2/HO1 pathway
por: Ebrahimpour, Afshin, et al.
Publicado: (2021)

Evaluation of an angiotensin Type 1 receptor blocker on the reconsolidation of fear memory
por: Swiercz, Adam P., et al.
Publicado: (2020)

Angiotensin receptor blockers and COVID-19
por: Saavedra, Juan M.
Publicado: (2020)

Angiotensin receptor blocker neprilysin inhibitors
por: Usuda, Daisuke, et al.
Publicado: (2021)

Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
por: Cho, Min Ae, et al.
Publicado: (2020)

Comparison of the structure and activity of thioredoxin 2 and thioredoxin 1 from Acinetobacter baumannii
por: Chang, Ye Ji, et al.
Publicado: (2023)

Sirt1 coordinates with ERα to regulate autophagy and adiposity
por: Tao, Zhipeng, et al.
Publicado: (2021)

Early prophylaxis of cardiomyopathy with beta-blockers and angiotensin receptor blockers in patients with Duchenne muscular dystrophy
por: Lee, Heirim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pe5c4r95jbbgd545c0hr1df5ek